K+和Ca2+通道在barbatus(巴西Boldo)对高血压大鼠血管扩张作用中的作用。

IF 3.4 4区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS
Cardiovascular Therapeutics Pub Date : 2023-11-17 eCollection Date: 2023-01-01 DOI:10.1155/2023/9948707
Jeniffer Cristóvão Moser, Rita de Cássia Vilhena da Silva, Philipe Costa, Luisa Mota da Silva, Nadla Soares Cassemiro, Arquimedes Gasparotto Junior, Denise Brentan Silva, Priscila de Souza
{"title":"K+和Ca2+通道在barbatus(巴西Boldo)对高血压大鼠血管扩张作用中的作用。","authors":"Jeniffer Cristóvão Moser, Rita de Cássia Vilhena da Silva, Philipe Costa, Luisa Mota da Silva, Nadla Soares Cassemiro, Arquimedes Gasparotto Junior, Denise Brentan Silva, Priscila de Souza","doi":"10.1155/2023/9948707","DOIUrl":null,"url":null,"abstract":"<p><p><i>Plectranthus barbatus</i>, popularly known as Brazilian boldo, is used in Brazilian folk medicine to treat cardiovascular disorders including hypertension. This study investigated the chemical profile by UFLC-DAD-MS and the relaxant effect by using an isolated organ bath of the hydroethanolic extract of <i>P. barbatus</i> (HEPB) leaves on the aorta of spontaneously hypertensive rats (SHR). A total of nineteen compounds were annotated from HEPB, and the main metabolite classes found were flavonoids, diterpenoids, cinnamic acid derivatives, and organic acids. The HEPB promoted an endothelium-dependent vasodilator effect (~100%; EC50 ~347.10 <i>μ</i>g/mL). Incubation of L-NAME (a nonselective nitric oxide synthase inhibitor; EC50 ~417.20 <i>μ</i>g/mL), ODQ (a selective inhibitor of the soluble guanylate cyclase enzyme; EC50 ~426.00 <i>μ</i>g/mL), propranolol (a nonselective <i>α</i>-adrenergic receptor antagonist; EC50 ~448.90 <i>μ</i>g/mL), or indomethacin (a nonselective cyclooxygenase enzyme inhibitor; EC50 ~398.70 <i>μ</i>g/mL) could not significantly affect the relaxation evoked by HEPB. However, in the presence of atropine (a nonselective muscarinic receptor antagonist), there was a slight reduction in its vasorelaxant effect (EC50 ~476.40 <i>μ</i>g/mL). The addition of tetraethylammonium (a blocker of Ca<sup>2+</sup>-activated K<sup>+</sup> channels; EC50 ~611.60 <i>μ</i>g/mL) or 4-aminopyridine (a voltage-dependent K<sup>+</sup> channel blocker; EC50 ~380.50 <i>μ</i>g/mL) significantly reduced the relaxation effect of the extract without the interference of glibenclamide (an ATP-sensitive K<sup>+</sup> channel blocker; EC50 ~344.60 <i>μ</i>g/mL) or barium chloride (an influx rectifying K<sup>+</sup> channel blocker; EC50 ~360.80 <i>μ</i>g/mL). The extract inhibited the contractile response against phenylephrine, CaCl<sub>2</sub>, KCl, or caffeine, similar to the results obtained with nifedipine (voltage-dependent calcium channel blocker). Together, the HEPB showed a vasorelaxant effect on the thoracic aorta of SHR, exclusively dependent on the endothelium with the participation of muscarinic receptors and K<sup>+</sup> and Ca<sup>2+</sup> channels.</p>","PeriodicalId":9582,"journal":{"name":"Cardiovascular Therapeutics","volume":"2023 ","pages":"9948707"},"PeriodicalIF":3.4000,"publicationDate":"2023-11-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10673663/pdf/","citationCount":"0","resultStr":"{\"title\":\"Role of K<sup>+</sup> and Ca<sup>2+</sup> Channels in the Vasodilator Effects of <i>Plectranthus barbatus</i> (Brazilian Boldo) in Hypertensive Rats.\",\"authors\":\"Jeniffer Cristóvão Moser, Rita de Cássia Vilhena da Silva, Philipe Costa, Luisa Mota da Silva, Nadla Soares Cassemiro, Arquimedes Gasparotto Junior, Denise Brentan Silva, Priscila de Souza\",\"doi\":\"10.1155/2023/9948707\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p><i>Plectranthus barbatus</i>, popularly known as Brazilian boldo, is used in Brazilian folk medicine to treat cardiovascular disorders including hypertension. This study investigated the chemical profile by UFLC-DAD-MS and the relaxant effect by using an isolated organ bath of the hydroethanolic extract of <i>P. barbatus</i> (HEPB) leaves on the aorta of spontaneously hypertensive rats (SHR). A total of nineteen compounds were annotated from HEPB, and the main metabolite classes found were flavonoids, diterpenoids, cinnamic acid derivatives, and organic acids. The HEPB promoted an endothelium-dependent vasodilator effect (~100%; EC50 ~347.10 <i>μ</i>g/mL). Incubation of L-NAME (a nonselective nitric oxide synthase inhibitor; EC50 ~417.20 <i>μ</i>g/mL), ODQ (a selective inhibitor of the soluble guanylate cyclase enzyme; EC50 ~426.00 <i>μ</i>g/mL), propranolol (a nonselective <i>α</i>-adrenergic receptor antagonist; EC50 ~448.90 <i>μ</i>g/mL), or indomethacin (a nonselective cyclooxygenase enzyme inhibitor; EC50 ~398.70 <i>μ</i>g/mL) could not significantly affect the relaxation evoked by HEPB. However, in the presence of atropine (a nonselective muscarinic receptor antagonist), there was a slight reduction in its vasorelaxant effect (EC50 ~476.40 <i>μ</i>g/mL). The addition of tetraethylammonium (a blocker of Ca<sup>2+</sup>-activated K<sup>+</sup> channels; EC50 ~611.60 <i>μ</i>g/mL) or 4-aminopyridine (a voltage-dependent K<sup>+</sup> channel blocker; EC50 ~380.50 <i>μ</i>g/mL) significantly reduced the relaxation effect of the extract without the interference of glibenclamide (an ATP-sensitive K<sup>+</sup> channel blocker; EC50 ~344.60 <i>μ</i>g/mL) or barium chloride (an influx rectifying K<sup>+</sup> channel blocker; EC50 ~360.80 <i>μ</i>g/mL). The extract inhibited the contractile response against phenylephrine, CaCl<sub>2</sub>, KCl, or caffeine, similar to the results obtained with nifedipine (voltage-dependent calcium channel blocker). Together, the HEPB showed a vasorelaxant effect on the thoracic aorta of SHR, exclusively dependent on the endothelium with the participation of muscarinic receptors and K<sup>+</sup> and Ca<sup>2+</sup> channels.</p>\",\"PeriodicalId\":9582,\"journal\":{\"name\":\"Cardiovascular Therapeutics\",\"volume\":\"2023 \",\"pages\":\"9948707\"},\"PeriodicalIF\":3.4000,\"publicationDate\":\"2023-11-17\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10673663/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cardiovascular Therapeutics\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1155/2023/9948707\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2023/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q2\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cardiovascular Therapeutics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1155/2023/9948707","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

摘要

barbatus,俗称巴西boldo,在巴西民间医学中用于治疗包括高血压在内的心血管疾病。采用UFLC-DAD-MS法研究了barbatus (HEPB)叶氢乙醇提取物在自发性高血压大鼠(SHR)主动脉上的化学性质,并采用离体器官浴法研究了其舒张作用。从HEPB中共鉴定出19个化合物,主要代谢产物为类黄酮、二萜、肉桂酸衍生物和有机酸。HEPB促进内皮依赖性血管扩张效应(~100%;EC50 ~347.10 μg/mL)。非选择性一氧化氮合酶抑制剂L-NAME的培养EC50 ~417.20 μg/mL), ODQ(可溶性鸟苷酸环化酶选择性抑制剂;EC50 ~426.00 μg/mL),心得安(非选择性α-肾上腺素能受体拮抗剂;EC50 ~448.90 μg/mL)或吲哚美辛(一种非选择性环加氧酶抑制剂;EC50 ~398.70 μg/mL)对HEPB引起的松弛无明显影响。然而,当阿托品(一种非选择性毒蕈碱受体拮抗剂)存在时,其血管松弛作用略有降低(EC50 ~476.40 μg/mL)。添加四乙基铵(Ca2+激活的K+通道阻滞剂);EC50 ~611.60 μg/mL)或4-氨基吡啶(一种电压依赖性K+通道阻滞剂;EC50 ~380.50 μg/mL)可显著降低提取物的松弛效应,而不受格列本脲(一种atp敏感的K+通道阻滞剂)的干扰;EC50 ~344.60 μg/mL)或氯化钡(一种内流整流K+通道阻滞剂;EC50 ~360.80 μg/mL)。该提取物抑制了对苯肾上腺素、CaCl2、KCl或咖啡因的收缩反应,与硝苯地平(电压依赖性钙通道阻滞剂)的结果相似。综上所述,HEPB对SHR的胸主动脉具有血管松弛作用,完全依赖于内皮细胞和毒碱受体以及K+和Ca2+通道的参与。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Role of K+ and Ca2+ Channels in the Vasodilator Effects of Plectranthus barbatus (Brazilian Boldo) in Hypertensive Rats.

Plectranthus barbatus, popularly known as Brazilian boldo, is used in Brazilian folk medicine to treat cardiovascular disorders including hypertension. This study investigated the chemical profile by UFLC-DAD-MS and the relaxant effect by using an isolated organ bath of the hydroethanolic extract of P. barbatus (HEPB) leaves on the aorta of spontaneously hypertensive rats (SHR). A total of nineteen compounds were annotated from HEPB, and the main metabolite classes found were flavonoids, diterpenoids, cinnamic acid derivatives, and organic acids. The HEPB promoted an endothelium-dependent vasodilator effect (~100%; EC50 ~347.10 μg/mL). Incubation of L-NAME (a nonselective nitric oxide synthase inhibitor; EC50 ~417.20 μg/mL), ODQ (a selective inhibitor of the soluble guanylate cyclase enzyme; EC50 ~426.00 μg/mL), propranolol (a nonselective α-adrenergic receptor antagonist; EC50 ~448.90 μg/mL), or indomethacin (a nonselective cyclooxygenase enzyme inhibitor; EC50 ~398.70 μg/mL) could not significantly affect the relaxation evoked by HEPB. However, in the presence of atropine (a nonselective muscarinic receptor antagonist), there was a slight reduction in its vasorelaxant effect (EC50 ~476.40 μg/mL). The addition of tetraethylammonium (a blocker of Ca2+-activated K+ channels; EC50 ~611.60 μg/mL) or 4-aminopyridine (a voltage-dependent K+ channel blocker; EC50 ~380.50 μg/mL) significantly reduced the relaxation effect of the extract without the interference of glibenclamide (an ATP-sensitive K+ channel blocker; EC50 ~344.60 μg/mL) or barium chloride (an influx rectifying K+ channel blocker; EC50 ~360.80 μg/mL). The extract inhibited the contractile response against phenylephrine, CaCl2, KCl, or caffeine, similar to the results obtained with nifedipine (voltage-dependent calcium channel blocker). Together, the HEPB showed a vasorelaxant effect on the thoracic aorta of SHR, exclusively dependent on the endothelium with the participation of muscarinic receptors and K+ and Ca2+ channels.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Cardiovascular Therapeutics
Cardiovascular Therapeutics 医学-心血管系统
CiteScore
5.60
自引率
0.00%
发文量
55
审稿时长
6 months
期刊介绍: Cardiovascular Therapeutics (formerly Cardiovascular Drug Reviews) is a peer-reviewed, Open Access journal that publishes original research and review articles focusing on cardiovascular and clinical pharmacology, as well as clinical trials of new cardiovascular therapies. Articles on translational research, pharmacogenomics and personalized medicine, device, gene and cell therapies, and pharmacoepidemiology are also encouraged. Subject areas include (but are by no means limited to): Acute coronary syndrome Arrhythmias Atherosclerosis Basic cardiac electrophysiology Cardiac catheterization Cardiac remodeling Coagulation and thrombosis Diabetic cardiovascular disease Heart failure (systolic HF, HFrEF, diastolic HF, HFpEF) Hyperlipidemia Hypertension Ischemic heart disease Vascular biology Ventricular assist devices Molecular cardio-biology Myocardial regeneration Lipoprotein metabolism Radial artery access Percutaneous coronary intervention Transcatheter aortic and mitral valve replacement.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信